For the quarter ending 2025-09-30, FGEN had -$1,866K decrease in cash & cash equivalents over the period. -$1,856K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 200,636 | -2,964 |
| Depreciation | 183 | 530 |
| Amortization of finance lease right-of-use assets | 9 | 18 |
| Net accretion of premium and discount on investments | -2 | 1 |
| Investment income in unconsolidated variable interest entity | 1,377 | 1,108 |
| Gain on divestiture | 52,163 | - |
| Loss on debt extinguishments | -6,583 | - |
| Impairment of property and equipment | 0 | 2,062 |
| Loss on disposal of property and equipment | 0 | 0 |
| Stock-based compensation | 662 | 4,725 |
| Dividend received from unconsolidated variable interest entity | 3,947 | - |
| Accounts receivable, net | -552 | 3,001 |
| Inventories | -1,030 | -4,210 |
| Prepaid expenses and other current assets | -3,295 | -51,479 |
| Operating lease right-of-use assets | -188 | -620 |
| Other assets | 1,621 | -549 |
| Accounts payable | -4,614 | -21,692 |
| Accrued and other liabilities | -17,448 | -30,700 |
| Operating lease liabilities, current | -134 | -434 |
| Deferred revenues | -143,858 | 7,537 |
| Accrued interest expense related to sale of future revenues | 1,975 | 3,684 |
| Accrued interest for finance lease liabilities | -8 | -11 |
| Operating lease liabilities, non-current | 3 | -205 |
| Other long-term liabilities | 311 | 103 |
| Proceeds from maturities of investments | - | 0 |
| Net cash provided by (used in) operating activities | -1,847 | 15,401 |
| Purchases of property and equipment | 9 | 29 |
| Proceeds from divestiture, net of cash transferred | 90,204 | - |
| Proceeds from sale of property and equipment | 0 | 0 |
| Purchases of available-for-sale securities | 3,035 | - |
| Net cash provided by investing activities | 87,160 | -29 |
| Repayments of senior secured term loan facilities | 75,000 | - |
| Payment of senior secured term loan facilities pay-off premium and fees | 5,550 | - |
| Repayments of finance lease liabilities | 2 | 2 |
| Cash paid for payroll taxes on restricted stock unit releases | 12 | 49 |
| Cash paid to non-controlling interest | 5,353 | - |
| Payment of issuance cost under atm program | 0 | 46 |
| Proceeds from issuance of common stock under employee stock plans | 0 | 0 |
| Net cash used in financing activities | -85,917 | -97 |
| Effect of exchange rate change on cash and cash equivalents | -1,262 | 2,388 |
| Net increase in cash and cash equivalents | -1,866 | 17,663 |
| Cash and cash equivalents at beginning of period | 102,178 | - |
| Cash and cash equivalents at end of period | 117,975 | - |
FIBROGEN INC (FGEN)
FIBROGEN INC (FGEN)